NIT
LGND icon

NumerixS Investment Technologies’s Ligand Pharmaceuticals LGND Stock Holding History

NumerixS Investment Technologies’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,443
Closed -$65K – 1192
2020
Q1 		$65K Buy
+1,443
New +$81.8K 0.03% 552
2019
Q3 		– Sell
-962
Closed -$68K – 1137
2019
Q2 		$68K Buy
+962
New +$70.9K 0.02% 703
2019
Q1 		– Sell
-641
Closed -$54K – 1235
2018
Q4 		$54K Sell
641
-1,122
-64% -$120K 0.02% 743
2018
Q3 		$301K Sell
1,763
-1,443
-45% -$218K 0.06% 445
2018
Q2 		$416K Sell
3,206
-1,122
-26% -$125K 0.09% 300
2018
Q1 		$437K Buy
4,328
+3,206
+286% +$317K 0.11% 210
2017
Q4 		$96K Sell
1,122
-4,168
-79% -$361K 0.02% 705
2017
Q3 		$449K Sell
5,290
-1,763
-25% -$140K 0.1% 260
2017
Q2 		$534K Sell
7,053
-3,527
-33% -$247K 0.08% 311
2017
Q1 		$699K Sell
10,580
-801
-7% -$52.7K 0.08% 305
2016
Q4 		$721K Buy
11,381
+2,885
+34% +$182K 0.09% 290
2016
Q3 		$541K Buy
8,496
+3,206
+61% +$235K 0.07% 359
2016
Q2 		$394K Buy
+5,290
New +$393K 0.05% 487

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return

NumerixS Investment Technologies's LGND Position: Q2 2020 in Review

NumerixS Investment Technologies sold out of Ligand Pharmaceuticals (LGND) in Q2 2020, closing a stake of 1,443 shares — an estimated $65K sold.

NumerixS Investment Technologies first reported a position in LGND in Q2 2016 and held it in 13 quarters. The position peaked at $721K in Q4 2016. 262 funds tracked by Wall St. Rank hold LGND as of Q2 2020.

  • NumerixS Investment Technologies reported no remaining Ligand Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 1,443 Ligand Pharmaceuticals shares in Q2 2020, an estimated $65K.
  • NumerixS Investment Technologies first reported a position in Ligand Pharmaceuticals in Q2 2016 and held it in 13 quarters.
  • NumerixS Investment Technologies's Ligand Pharmaceuticals position peaked at $721K in Q4 2016.
  • 262 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2020.

Based on NumerixS Investment Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.